Support World Hepatitis Testing Week 2026

Platinum

Find out more about our partnership and the activities we are delivering together this World Hepatitis Testing Week here.

Silver

Steadfast in our commitment and support for HCV elimination by 2030.

At AbbVie, we’re supporting people with HCV by identifying and successfully linking them to appropriate care – one at a time.

We are passionate and committed to finding and treating populations considered among the “missing millions” to achieve the WHO’s target of HCV elimination by 2030.

About Cepheid

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company’s GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com

Add your organisation’s support and join the movement committed to increasing testing for viral hepatitis – a crucial step toward its elimination.

Eliminating hepatitis as a public health threat needs everyone to work together. With over a decade of experience delivering World Hepatitis Day, and 450 members in 130 countries, the World Hepatitis Alliance is uniquely placed to deliver this global campaign – but we can only do so with the support of our partners.

Sponsorship empowers thousands of organisations and people living with viral hepatitis to have a voice. It enables us and our members to build, reinforce and champion a movement demanding action. And it provides the foundation of a campaign we know will raise awareness, invoke conversations, support advocacy and drive short- and long-term change.

Sponsoring World Hepatitis Testing Week 2026 will: 

  • Demonstrate your support for people living with viral hepatitis and the organisations that serve them. 
  • Show your understanding that resources and support are needed to build a stronger movement, increase testing, and ensure the millions of people currently living unaware of hepatitis start to receive the diagnosis and support they need.
  • Signal to decision makers the pressing and continuing need to invest in testing and treatment programmes.

 

Sponsors of our campaigns have seen strong performance of their own campaigns running alongside ours, enabling them to generate a better return on their own communication strategy.

Find the standard partnership packages here. Outside of these packages, we can also collaborate on initiatives like donations of tests, promotion of screening drives, or in-country programmes. 

Confirm your commitment to eliminate hepatitis, reach out today: partnerships@worldhepatitisalliance.org

Download the World Hepatitis Testing Week Partnership Opportunities brochure here.

Supporters of World Hepatitis Testing Week 2025

Europe

  • 53,000 people die each year from viral hepatitis.
  • An estimated 10.6 million people live with hepatitis B. Only 16% have been diagnosed, and less than 2% are receiving the treatment they would need.
  • An estimated 8.6 million people live with hepatitis C. Only 29% have been diagnosed, and just 9% are receiving the treatment they would need.